Approval · Notice of Compliance 22798 · 2019
CEFADROXIL: Notice of Compliance 22798
Issued October 18, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22798
- Date
- October 18, 2019
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Labelling Only
- Canadian reference product
- DURICEF (Bristol-Myers Squibb S.R.L.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CEFADROXIL | 02240600 | Approved |
Medicinal ingredients
- CEFADROXIL 500 MG per CAP